Jacobsen Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$572K Buy
4,758
+47
+1% +$5.43K 0.19% 50
2025
Q4
$496K Sell
4,711
-178
-4% -$16.7K 0.16% 56
2025
Q3
$410K Buy
4,889
+804
+20% +$66.2K 0.14% 62
2025
Q2
$323K Buy
4,085
+956
+31% +$76K 0.12% 73
2025
Q1
$281K Sell
3,129
-465
-13% -$43.4K 0.12% 73
2024
Q4
$358K Buy
3,594
+233
+7% +$24K 0.15% 53
2024
Q3
$382K Sell
3,361
-525
-14% -$62.4K 0.16% 51
2024
Q2
$481K Buy
3,886
+561
+17% +$72.3K 0.21% 44
2024
Q1
$439K Buy
3,325
+190
+6% +$23.4K 0.2% 44
2023
Q4
$342K Sell
3,135
-651
-17% -$67.6K 0.17% 53
2023
Q3
$390K Sell
3,786
-44
-1% -$4.74K 0.21% 49
2023
Q2
$442K Buy
3,830
+489
+15% +$55.5K 0.23% 46
2023
Q1
$355K Buy
+3,341
New +$361K 0.19% 51

Other funds holding MRK

Jacobsen Capital Management's MRK Position: Q1 2026 in Review

Jacobsen Capital Management increased its Merck (MRK) stake by 1% in Q1 2026, buying an estimated $5.43K and bringing the position to 4,758 shares worth $572K. The position accounts for 0.19% of the portfolio, ranked #50.

Jacobsen Capital Management first reported a position in MRK in Q1 2023 and has held it in 13 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Jacobsen Capital Management held 4,758 shares of Merck worth $572K as of Q1 2026.
  • Jacobsen Capital Management bought 47 Merck shares in Q1 2026, an estimated $5.43K.
  • Merck made up 0.19% of Jacobsen Capital Management's portfolio in Q1 2026, its #50 holding.
  • Jacobsen Capital Management first reported a position in Merck in Q1 2023 and has held it in 13 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Jacobsen Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.